Cargando…
Annexin A1 Is Associated with Adverse Clinical Outcomes in Patients with COVID-19
Severe coronavirus disease 2019 (COVID-19) is characterized by hyperinflammation, vascular damage, and hypercoagulability. Insufficient responses of Annexin A1 (AnxA1), a pro-resolving inhibitor of neutrophil infiltration and activation, might contribute to a severe course of the disease. We longitu...
Autores principales: | Busch, Matthias H., Timmermans, Sjoerd A. M. E. G., Aendekerk, Joop P., Ysermans, Renée, Amiral, Jean, Damoiseaux, Jan G. M. C., Reutelingsperger, Chris P., van Paassen, Pieter |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9781714/ https://www.ncbi.nlm.nih.gov/pubmed/36556102 http://dx.doi.org/10.3390/jcm11247486 |
Ejemplares similares
-
Adding low dose cyclophosphamide to rituximab for remission-induction may prolong relapse-free survival in patients with ANCA vasculitis: A retrospective study
por: Ysermans, Renée, et al.
Publicado: (2022) -
Thrombin formation via the intrinsic coagulation pathway and von Willebrand factor reflect disease severity in COVID-19
por: Busch, Matthias H., et al.
Publicado: (2022) -
Functional and Genetic Landscape of Complement Dysregulation Along the Spectrum of Thrombotic Microangiopathy and its Potential Implications on Clinical Outcomes
por: Timmermans, Sjoerd A.M.E.G., et al.
Publicado: (2021) -
Vascular Remodeling in Pulmonary Arterial Hypertension: The Potential Involvement of Innate and Adaptive Immunity
por: Tobal, Rachid, et al.
Publicado: (2021) -
Spondylitis as a Rare Manifestation of Granulomatosis With Polyangiitis
por: Busch, Matthias H., et al.
Publicado: (2020)